About US
Contact us
-
Chinese officials intent on 'Anhui model' for price cutsAs China's National People's Congress ends in Beijing, Chinese politicians are repeating their pledge to make healthcare more affordable. Unfortunately for drugmakers, that means officials are also pl2012/3/15
-
After big hike in 2011, GSK CEO's pay set to jump againGlaxoSmithKline ($GSK) CEO Andrew Witty (photo) saw a big pay hike in 2011--and he's due another increase this year, the company's compensation committee says.Last year, Witty collected a pay package2012/3/14
-
Japan may open door to more foreign-approved drugsHere's another hint of Japan's new openness to Big Pharma: a proposed compassionate use program. The government is considering allowing drugs for serious diseases to be sold in Japan while they're sti2012/3/14
-
FDA drafts rules for prior review of DTC television adsMoving toward mandatory review of direct-to-consumer advertising, the FDA has released draft rules for which sorts of materials need review--and in which form they can be submitted. The agency guidanc2012/3/13
-
Pfizer aims to jump start stalled arthritis-pain drugsPfizer ($PFE) is making a pitch for reviving the anti-nerve growth factor drug it shelved two years ago on safety concerns. The arthritis pain treatment is one of several anti-NGF drugs, so if FDA all2012/3/13
-
Biopharma workers balance good, bad and ugly in new surveyFirst, the good news about what biopharma employees are thinking today: Things aren't as bad as they used to be--for some. That's the bottom line of a new industry survey conducted by Challenger, Gray2012/3/12
-
Bayer Healthcare posts big growth in Asia PacificBayer Healthcare is on a roll in Asia. The German company toted up a 9.4% increase in Asia Pacific sales last year, for a regional total of 3.6 billion euros, or $4.8 billion. And it has even bigger a2012/3/12
-
Bayer, Novartis circle Pfizer's animal health unitPfizer's ($PFE) animal health unit may not be to Sanofi's ($SNY)taste, but Bayer and Novartis ($NVS)appear to have an appetite for it. Sources close to the process tell Reuters that Bayer is shopping2012/3/9
-
SFDA specifies relevant requirements for the registration of medical devices with adjusted management classificationIn order to further standardize the registration of medical devices, and in accordance with relevant regulations, the State Food and Drug Administration (SFDA) recently issued a notice to specify the2012/3/9
-
Roche can shop around if Illumina bid fails, Humer saysPlay hard to get all you want, Illumina. Roche Chairman Franz Humer says there are plenty of other fish in the gene-sequencing sea. "Illumina is not the only gene-sequencing company, and there are oth2012/3/8